Novo Nordisk A/S plans to sell bonds for the first time in more than two years to help finance its large program to expand production of its blockbuster treatments.
Ozempic Maker Novo Nordisk Plans Bond Sale to Fund ExpansionVodafone, Deutsche Telekom Cash Swells: EMEA Earnings Week AheadTop Critical Mineral Miner CBMM Sees Opportunity in EV BatteriesChina Takes Advantage of Cheap Gas and Coal to Rebuild StocksGreyhound Owner Flix, Retailer Tendam Eye IPOs in Coming WeeksSaudi Wealth Fund Said to Invite Bank Pitches for Nupco IPORussia’s Post-Election Spending Sends Budget Into Deep Deficit‘Stunning’ Solar Activity Is a Warning to Grid OperatorsRomania’s...
5 Billion DealVodafone, Deutsche Telekom Cash Swells: EMEA Earnings Week AheadTop Critical Mineral Miner CBMM Sees Opportunity in EV BatteriesChina Takes Advantage of Cheap Gas and Coal to Rebuild StocksBHP Says Anglo American Has Rejected Revised Proposal‘Stunning’ Solar Activity Is a Warning to Grid OperatorsIndian Renewable Energy Firm Plans Maiden Dollar Bond SaleThe Gas Giant That Has Quietly Taken Over EuropeBob Menendez Bribe Trial Over Gold Bars, Cash Begins in New YorkThe Daily Chase:...
Philippines Latest News, Philippines Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Ozempic Subsidies Cut in Novo Nordisk’s Home Country of DenmarkSubsidies for Ozempic will be restricted in Novo Nordisk A/S’s home country of Denmark due to rising public spending on the blockbuster diabetes medicine, which is increasingly being used as a weight-loss treatment.
Read more »
CEO of Oreo Maker Mondelez Sees Very Limited Impact From OzempicEven with appetite-suppressing drugs, people will keep eating Oreo cookies, according to the company that makes them.
Read more »
US Senate committee investigates pricing of Novo's Ozempic and WegovyExplore stories from Atlantic Canada.
Read more »
US Senate committee investigates pricing of Novo's Ozempic and WegovyExplore stories from Atlantic Canada.
Read more »
U.S. Senate committee investigates pricing of Novo’s Ozempic and WegovySenator Bernie Sanders sent a letter to Novo’s CEO seeking more information on U.S. prices for the two drugs, which are higher than the prices in other countries
Read more »
Novo Asks for More Time to Answer Sanders on Ozempic’s PriceNovo Nordisk A/S is asking for more time to answer questions from US Senator Bernie Sanders on the prices of Ozempic and Wegovy, the company’s blockbuster drugs for diabetes and weight loss.
Read more »